Index of artpub/2024/305631/

Di Giacomo, Anna Maria
A phase II study of retifanlimab, a humanized anti-PD-1 monoclonal antibody, in patients with solid tumors (POD1UM-203)
2024
https://ddd.uab.cat/record/305631